In Brief: U.S. Bioscience
Executive Summary
U.S. Bioscience: Company is awarded a patent covering a "novel method of manufacturing crystalline amifostine (Ethyol) and the resulting thermally stable, sterile crystalline amifostine suitable for reconstitution for parenteral administration," West Conshohocken, Penn.-based USB reports. Ethyol was recommended for approval by an FDA advisory committee June 9 ("The Pink Sheet" June 12, p. 3)...